UK Food Standards Agency recognises Pureis with first-ever Positive Safety Assessment for CBD

This article takes an in depth look at the regulatory process that CBD products must go through for UK sale as a ‘Novel Foods’ supplement, and why it’s important that consumers choose products that have been given a thumbs up for safety by the Food Standards Agency (FSA). 

Pureis® Ultra Pure CBD has made history. The UK government’s regulatory body – the Food Standards Agency (FSA) has issued its first ever Positive Safety Assessment. It’s the first time a CBD product has been granted a ‘Positive Opinion’ by the FSA which means that within a matter of months the legislative process for full approval of Pureis Ultra Pure CBD will be complete.

This announcement is good news for Chanelle McCoy Health, the owners of the science- backed Pureis brand and an equally positive sign for the wider industry as it marks a watershed moment for CBD gaining legitimacy to be sold as a bona fide food supplement. Where consumers can take the most reassurance however is that both now, and in the future, only brands who undertake the most rigorous Safety Clinical Studies will gain this FSA Positive Safety Assessment.

Why is CBD classified as a ‘Novel Food’?CBD is classified as a Novel Food which refers to food products that are either entirely new or produced using methods not previously used for human consumption. This category includes CBD, as it’s a relatively recent addition to the mainstream food market.

Novel Food regulations ensure the safety and transparency of these new products. By undergoing a rigorous approval process, global authorities ensure that consumers can be confident they’re getting a high quality and safe CBD product.

A Novel Food authorisation/approval requires extensive safety studies to be carried out by internationally recognized Clinical Research Organisations adhering to Good Laboratory Practice and Good Clinical Practice principles. This includes; clinical testing to ensure product purity and consistency and toxicological evaluations to comply to all the consumer safety requirements.

What makes Pureis products worthy of an FSA Positive Safety Assessment?
This endorsement from the FSA Scientific Committee indicates that Pureis® Ultra Pure CBD has successfully fulfilled the rigorous criteria necessary to progress to the final stage of the Novel Food Licensing process.

The UK is the first authority globally to conclude and publish safety assessments for CBD food supplement products. Pureis® Ultra Pure CBD is the world’s leading brand of Lab-Made CBD food supplements which are manufactured in the UK and rigorously tested, contain 0% THC, are non- addictive and sustainably produced. Pureis® offers a range of products, including CBD oil drops, oral sprays and capsules, in different strengths and flavours.

Only CBD brands who have invested significantly in Safety Clinical Studies have achieved this Positive Safety Assessment, taking Pureis nearly a decade to achieve this. Consumers will now have the added reassurance of the FSA endorsement to safely choose a product, empowering them to shop the Pureis range with confidence.